Compare Abeona Therapeutics Inc (ABEO) vs McCormick & Company, Incorporated (MKC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs McCormick & Company, Incorporated — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while McCormick & Company, Incorporated trades at $53 (market cap $14.22B). The key difference: McCormick & Company, Incorporated is far larger — about 33.8× Abeona Therapeutics Inc's market cap, and McCormick & Company, Incorporated pays a 3.63% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | MKC | |
|---|---|---|
Market Cap | $421.19M | $14.22B |
Sector | Health | Consumer Staples |
52-Week High | $7.45 | $72.26 |
52-Week Low | $4.17 | $45.60 |
Enterprise Value | $276.10M | $18.82B |
Dividend Yield | — | 3.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About McCormick & Company, Incorporated
In its 130-year history, McCormick has grown to become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond end consumers, McCormick's customer base also includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers, with about 30% of sales generated beyond its home turf to include 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and the recently acquired Cholula brand.
Read more on MKC →
